These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 25801887

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
    Popp AW, Senn R, Curkovic I, Senn C, Buffat H, Popp PF, Lippuner K.
    Osteoporos Int; 2017 Jun; 28(6):1995-2002. PubMed ID: 28299378
    [Abstract] [Full Text] [Related]

  • 5. Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion.
    Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, Valenti MT, Dalle Carbonare L, Lo Cascio V.
    J Bone Miner Res; 2010 Mar; 25(3):447-54. PubMed ID: 20200999
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.
    Anastasilakis AD, Polyzos SA, Delaroudis S, Bisbinas I, Sakellariou GT, Gkiomisi A, Papadopoulou E, Gerou S, Makras P.
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):816-22. PubMed ID: 22676573
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of amino-bisphosphonates on circulating γδ T cells.
    Rossini M, Adami S, Viapiana O, Fracassi E, Ortolani R, Vella A, Zanotti R, Tripi G, Idolazzi L, Gatti D.
    Calcif Tissue Int; 2012 Dec; 91(6):395-9. PubMed ID: 23052225
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. No effect of rosuvastatin in the zoledronate-induced acute-phase response.
    Makras P, Anastasilakis AD, Polyzos SA, Bisbinas I, Sakellariou GT, Papapoulos SE.
    Calcif Tissue Int; 2011 May; 88(5):402-8. PubMed ID: 21305270
    [Abstract] [Full Text] [Related]

  • 12. Acute-phase reaction induced by zoledronate and its effect on prognosis of patients with advanced non-small cell lung cancer.
    Izumi H, Yamasaki A, Takeda K, Kodani M, Touge H, Tanaka N, Yanai M, Ueda Y, Sakamoto T, Nishii-Ito S, Makino H, Yamaguchi K, Igishi T, Shimizu E.
    Lung Cancer; 2018 Aug; 122():200-205. PubMed ID: 30032832
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis.
    Catalano A, Morabito N, Atteritano M, Basile G, Cucinotta D, Lasco A.
    Calcif Tissue Int; 2012 Apr; 90(4):279-85. PubMed ID: 22350110
    [Abstract] [Full Text] [Related]

  • 14. Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease.
    Merlotti D, Rendina D, Muscariello R, Picchioni T, Alessandri M, De Filippo G, Materozzi M, Bianciardi S, Franci MB, Lucani B, Cenci S, Strazzullo P, Nuti R, Gennari L.
    J Clin Endocrinol Metab; 2020 Mar 01; 105(3):. PubMed ID: 31634910
    [Abstract] [Full Text] [Related]

  • 15. Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience.
    George S, Weber DR, Kaplan P, Hummel K, Monk HM, Levine MA.
    J Clin Endocrinol Metab; 2015 Nov 01; 100(11):4163-71. PubMed ID: 26308295
    [Abstract] [Full Text] [Related]

  • 16. Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women.
    Thompson K, Keech F, McLernon DJ, Vinod K, May RJ, Simpson WG, Rogers MJ, Reid DM.
    Bone; 2011 Jul 01; 49(1):140-5. PubMed ID: 21047568
    [Abstract] [Full Text] [Related]

  • 17. Acute phase response after zoledronic acid is associated with long-term effects on white blood cells.
    Rossini M, Adami S, Viapiana O, Tripi G, Zanotti R, Ortolani R, Vella A, Troplini S, Gatti D.
    Calcif Tissue Int; 2013 Sep 01; 93(3):249-52. PubMed ID: 23748711
    [Abstract] [Full Text] [Related]

  • 18. Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.
    Dieli F, Vermijlen D, Fulfaro F, Caccamo N, Meraviglia S, Cicero G, Roberts A, Buccheri S, D'Asaro M, Gebbia N, Salerno A, Eberl M, Hayday AC.
    Cancer Res; 2007 Aug 01; 67(15):7450-7. PubMed ID: 17671215
    [Abstract] [Full Text] [Related]

  • 19. The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial.
    Black DM, Reid IR, Napoli N, Ewing SK, Shiraki M, Nakamura T, Takeuchi Y, Schafer AL, Kim TY, Cauley JA.
    J Bone Miner Res; 2022 Jan 01; 37(1):21-28. PubMed ID: 34585443
    [Abstract] [Full Text] [Related]

  • 20. Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.
    Billington EO, Horne A, Gamble GD, Maslowski K, House M, Reid IR.
    Osteoporos Int; 2017 Jun 01; 28(6):1867-1874. PubMed ID: 28233020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.